Fluid bolus effect on heart and blood flow
Part of Heart & circulation, Kidney & urinary clinical trials.
This study looks at how a standard IV fluid bolus affects blood flow and heart function in ICU patients. It aims to better understand the body's response to this common treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are in the intensive care unit (ICU).
- You already have a monitor tracking your heart function and blood flow.
- Your doctor has decided to give you a specific amount of IV fluid (6 mL per kg of your weight) to help your blood volume.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study watches how the right side of your heart responds when doctors give you extra fluids to improve blood flow during a critical illness. Understanding this response may help doctors make better decisions about fluid treatment in the ICU.
This trial is testing a new system called Argos to see if it can measure how much blood your heart pumps more easily than current methods. It is for patients already in the ICU who need a quick change in fluids or blood pressure medicine.
This study checks whether a specific heart ultrasound measurement can help doctors decide if you will benefit from extra fluid during early emergency treatment for shock. It may help avoid unnecessary fluids and support faster, safer decision-making.
This trial studies different ways to measure how much extra fluid your body can handle when you are in shock. The goal is to see which method works best and helps doctors make better decisions about fluid treatment.
This study tests a method called tissue perfusion pressure to see if it can accurately predict whether a patient in shock will benefit from getting more fluids. It aims to help doctors make better decisions about fluid treatment in the ICU.
This trial studies whether “blood pressure–supporting” medicines (given through a central line) work well and safely for adults in the ICU who have shock. Your team may use the results to improve care for people with low blood pressure and poor blood flow to organs.
Hear when a new Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.